drugset / Trial / NCT00375596
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Parallel-group
Summary
This study will evaluate the safety and efficacy of a new allergy medication
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped (Enrollment): “Study withdrawn without starting or enrolling subjects due to a business decision to not proceed with the project.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketotifen | Small molecule | — | — |